US Stock MarketDetailed Quotes

PMCB PharmaCyte Biotech

Watchlist
  • 1.720
  • +0.050+2.99%
Close Dec 13 16:00 ET
  • 1.500
  • -0.220-12.79%
Post 19:45 ET
13.21MMarket Cap2.69P/E (TTM)

About PharmaCyte Biotech Company

PharmaCyte Biotech, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of treatments for cancer and diabetes. It focuses on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box, which will be used as a platform for the development of treatments for inoperable pancreatic cancer and other solid cancerous tumors, and diabetes. The company was founded on October 28, 1996 and is headquartered in Las Vegas, NV.

Company Profile

SymbolPMCB
Company NamePharmaCyte Biotech
Listing DateAug 10, 2021
Founded1996
CEOMr. Joshua Nathaniel Silverman
MarketNASDAQ
Employees2
Fiscal Year Ends04-30
Address3960 Howard Hughes Parkway,Suite 500
CityLas Vegas
ProvinceNevada
CountryUnited States of America
Zip Code89169
Phone1-917-595-2850
Websitehttp://pharmacyte.com

Company Executives

  • Name
  • Position
  • Salary
  • Joshua Nathaniel Silverman
  • Interim Chairman of the Board, Interim Chief Executive Officer and Interim President
  • 197.92K
  • Carlos A. Trujillo
  • Chief Financial Officer and Principal Accounting Officer
  • 385.26K
  • Dr. Michael M. Abecassis
  • Independent Director
  • 38.80K
  • Robert Weinstein
  • Independent Director
  • 18.75K
  • Wayne R. Walker
  • Independent Director
  • 12.50K
  • Jonathan L. Schechter
  • Independent Director
  • 31.25K
Heat List
US
Overall
Symbol
Price
% Chg

No Data